Company Earnings Update 4 minutesRegister for Free AccessCVS Health (NYSE: CVS) 1Q19 Results: Strong Aetna Performance Boosts Revenues, Prompts Guidance Raise Coresight Research May 3, 2019 Executive Summary CVS Health reported 1Q19 revenues of $61.6 billion, ahead of the consensus estimate and up 34.8% year over year. Adjusted EPS was $1.62, up 9.5% year over year and above the consensus estimate. CVS closed its acquisition of Aetna in Novesmber 2018, so this is the first full quarter of combined operations. For FY19, CVS raised adjusted EPS guidance to $6.75-6.90 from $6.68-6.88. Please Login to read the full report. Not a member? Register for a free user account. This document was generated for Other research you may be interested in: Where Do Shoppers Cross the Aisle?: US Consumer Tracker Extra, May 2023Shoptalk Europe 2024 Day Three: Highlighting the Importance of Data Sharing, Retail Media and MoreNext-Generation Product Information Management: From Spreadsheets to AI—Free InfographicHoliday 2024—Deck the Halls! Holiday Shopping Accelerates, with Décor Top of the List: US Consumer Survey Insights
